Assignee
ICM CO LTD
KR·3 granted patents·1 pending application·0 citations·filing 2017–2022
Top patents by PatentIndex Score
4 records- 0162US11154590B2Nkx3.2 fragment and pharmaceutical composition comprising same as active ingredientICM CO LTD·Filed 2020·Granted Oct 26, 2021·0 cites·18 claims
- 0257US2023149506A1Pharmaceutical composition for treating retinal dystrophies, comprising nkx3.2 and fragment thereof as active ingredientsICM CO LTD·Filed 2022·Application pending·0 cites
- 0355US11235025B2Nkx3.2 fragment and pharmaceutical composition comprising same as active ingredientICM CO LTD·Filed 2017·Granted Feb 1, 2022·0 cites·15 claims
- 0454US11628203B2Pharmaceutical composition for treating retinal dystrophies, comprising Nkx3.2 and fragment thereof as active ingredientsICM CO LTD·Filed 2018·Granted Apr 18, 2023·0 cites·5 claims
Join the waitlist — get patent alerts
Get an alert when ICM CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →